Spotlight: management of primary biliary cholangitis

Liver disease is becoming more prevalent in the UK, and it is the only major chronic disease where death rates are rising.¹

Over the past few decades, new medications, technologies, and other innovations have been developed to try and tackle this growing need, but innovations in rare liver disease are still lacking.

For example, there have been no new effective treatments for primary biliary cholangitis (PBC) – a rare, auto-immune cholestatic liver disease – for more than a decade.

New User Registration

Choose a Username*

First Name*

Last Name*

Job Title*

---- Select One ----Doctor (Hospital)Doctor (GP)NursePharmacistStudentAcademicPharmaOther Healthcare Professional

Email*

Confirm Email*

Password*

Confirm Password*

Input the code:

*Required field